Moderate

Oesophageal varices — screening & primary prophylaxis

Variceal prophylaxis · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Cirrhosis warrants assessment for varices and primary prophylaxis of high-risk varices to prevent first bleeding; non-selective beta-blockers (including carvedilol) or band ligation are used based on variceal size and risk.

Red flags

  • Any haematemesis or melaena (acute variceal bleed)
  • Large varices with red signs
  • Decompensation (ascites, encephalopathy)
  • Hypotension limiting beta-blockade

Assessment

Differential diagnosis

  • Gastric varices
  • Portal hypertensive gastropathy
  • Non-cirrhotic portal hypertension
  • Peptic ulcer (bleeding source)
  • GAVE

Investigations

  • Assess for clinically significant portal hypertension (platelet count, liver stiffness)
  • Screening upper GI endoscopy where indicated (Baveno criteria)
  • Transient elastography (liver stiffness) ± spleen stiffness
  • FBC (platelets), LFTs, Child-Pugh/MELD
  • Ultrasound for splenomegaly/portosystemic collaterals

Management

  • Identify patients with compensated cirrhosis and assess for clinically significant portal hypertension
  • Apply Baveno criteria — patients with low liver stiffness and normal platelets can avoid screening endoscopy
  • Perform screening endoscopy where portal hypertension is likely or criteria not met
  • Grade varices (small vs medium/large) and look for high-risk stigmata (red signs)
  • Start a non-selective beta-blocker (carvedilol preferred) for primary prophylaxis of high-risk varices
  • Titrate beta-blocker to heart rate ~55–60 bpm as tolerated, monitoring blood pressure
  • Offer endoscopic variceal band ligation if beta-blockers are contraindicated or not tolerated
  • Use carvedilol also to reduce decompensation in compensated significant portal hypertension
  • Avoid combining beta-blocker and banding routinely for primary prophylaxis
  • Re-scope at defined intervals if no prophylaxis started, adjusting as varices progress
  • Treat the underlying liver disease and reinforce abstinence/weight loss to reduce portal pressure

Drugs & doses

Carvedilol 6.25 mg PO once daily, up to 12.5 mg/day (preferred NSBB)
Propranolol 40 mg PO twice daily, titrated to heart rate ~55–60
Nadolol 40 mg PO once daily (alternative)

Disposition

Outpatient hepatology surveillance; endoscopy service for banding where indicated.

Complications & pitfalls

  • First variceal haemorrhage
  • Beta-blocker intolerance (hypotension, bradycardia)
  • Banding-induced ulcer bleeding
  • Progression to decompensated cirrhosis

Exam pearls

  • Carvedilol is the preferred non-selective beta-blocker and also reduces decompensation in compensated significant portal hypertension
  • Baveno criteria (platelets >150, liver stiffness <20 kPa) let many patients safely skip screening endoscopy
  • For primary prophylaxis choose EITHER a beta-blocker OR banding, not both
  • Beta-blockers protect against first bleed; stop/hold them in refractory ascites with hypotension

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.